Jinwen Wang

Jinwen Wang

Auto-generated profile, based on publicly available information

Jinwen Wang

Department of Orthopedics The First Affiliated Hospital with Nanjing Medical University Nanjing China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
HZHao Zhou
Hao Zhou
YXYong Xiao
Yong Xiao
XXXinchen Xue
Xinchen Xue
JLJiuxiang Liu
Jiuxiang Liu
HXHongtao Xu
Hongtao Xu
WFWeimin Fan
Weimin Fan
Osteoarthritis (OA) and diabetes predominantly affect middle-aged and elderly populations, with OA patients frequently presenting with comorbid diabetes. Despite evidence that diabetes aggravates OA progression, the underlying mechanisms are not fully understood. Here, we demonstrate that hyperglycaemia exacerbates OA progression through CD11b lactylation-mediated impairment of macrophage efferocytosis. Mechanistically, hyperglycemia enhances glycolysis in synovial macrophages, leading to lactate accumulation and CD11b lactylation at K575. This post-translational modification alters the conformation of the CD11b protein, impairing recognition of apoptotic cells and compromising synovial macrophage efferocytosis, thereby exacerbating inflammation and accelerating OA progression. Additionally, we identify CBP as a lactyl-transferase whose targeted knockdown in synovial macrophages effectively reduces lactylation levels, restores efferocytosis function, and delays hyperglycemia-associated OA progression. Collectively, our findings represent an important molecular mechanism by which hyperglycemia aggravates OA and suggest that targeting CBP could be utilized as therapeutic strategy for mitigating hyperglycemia-associated OA.

16 March 2025 in Injury
Verified
Journal Article
Closed access
JWJinwen Wang
Jinwen Wang
YFYitian Feng
Yitian Feng
HCHui Cheng
Hui Cheng
KQKaoliang Qian
Kaoliang Qian
BWBin Wan
Bin Wan
JHJun Hu
Jun Hu

5 August 2026 in Advanced Science
Verified
Journal Article
Open access
PDF file
JWJinwen Wang
Jinwen Wang
WXWenhui Xie
Wenhui Xie
LYLei Yang
Lei Yang
ZWZhengrong Wang
Zhengrong Wang
YHYi Huang
Yi Huang
JHJun Hu
Jun Hu
Arthritis may influence neurodegenerative risk, but directionality and mediators remain unclear. This study integrates population survival analysis, Mendelian randomization, transcriptomic mapping, and mouse perturbation to map osteoarthritis (OA)/rheumatoid arthritis (RA) links with five neurodegenerative outcomes and prioritize mediators. In 310 162 European‐ancestry UK Biobank participants, Cox models associate OA with higher risks of Alzheimer's disease (AD; hazard ratio: 1.13, 95% confidence interval: 1.04–1.22), Parkinson's disease (PD; 1.10, 1.00–1.21), and disorders of autonomic nervous system (DANS; 1.36, 1.06–1.74), and RA with higher AD risk (1.37, 1.13–1.67) (all p < 0.05), but not incident PD. Mendelian randomization prioritizes a modest protective genetic effect of RA on PD (odds ratio: 0.93, 0.88–0.99; p = 0.015), without reverse causation. Transcriptome‐wide association and colocalization analyses identify shared RA–PD genes and prioritize Ring Finger Protein 40 ( RNF40 ). In a collagen‐induced arthritis (CIA) and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) mouse model, CIA attenuates dopaminergic injury, whereas systemic Rnf40 knockdown alleviates arthritis but exacerbates Parkinsonian pathology. Endogenous RNF40 is induced in arthritic joints but remains stable in midbrain. These cross‐layer data define arthritis–neurodegeneration connections and nominate RNF40 as a context‐dependent joint–brain candidate linking inflammatory arthritis with dopaminergic vulnerability.